FDA
label_change
· 2023-12-01
FDA Approved: NALBUPHINE HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
Summary
FDA approved a supplemental application for nalbuphine hydrochloride submitted by Hospira, resulting in changes to the product labeling.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NALBUPHINE HYDROCHLORIDE (NALBUPHINE HYDROCHLORIDE)